Pediatrix Medical Group (MEX:MD) ROCE %: 10.92% (As of Mar. 2026)


MEX:MD Pediatrix Medical Group Inc MEX:MD
59 GF Score
Price MXN323.00
GF Value MXN177.74
! 7 Warning Signs
View Full Analysis

What is Pediatrix Medical Group ROCE %?

Pediatrix Medical Group MEX:MD 59 ROCE % is 10.92% as of Mar. 2026. GuruFocus rates MEX:MD with a GF Score™ of 59/100 and a GF Value™ of MXN177.74. The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pediatrix Medical Group's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.92%.

Pediatrix Medical Group  (MEX:MD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pediatrix Medical Group ROCE % Related Terms

Pediatrix Medical Group ROCE % Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group ROCE % Chart

Pediatrix Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.98 5.58 -0.31 -3.78 13.22

Pediatrix Medical Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.49 13.82 21.18 11.85 10.92
MEX:MD
59GF Score
Pediatrix Medical Group Inc MEX:MD
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pediatrix Medical Group ROCE % Calculation

Pediatrix Medical Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=4544.585/( ( (44896.065 - 9053.668) + (40453.334 - 7553.931) )/ 2 )
=4544.585/( (35842.397+32899.403)/ 2 )
=4544.585/34370.9
=13.22 %

Pediatrix Medical Group's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=3398.008/( ( (40453.334 - 7553.931) + (37333.009 - 7981.958) )/ 2 )
=3398.008/( ( 32899.403 + 29351.051 )/ 2 )
=3398.008/31125.227
=10.92 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.92% mean?
Pediatrix Medical Group (MEX:MD) has a ROCE % of 10.92% as of Mar. 2026.
Is Pediatrix Medical Group's ROCE % too high?
Pediatrix Medical Group's current ROCE % is 10.92%. The Healthcare Providers & Services industry median ROCE % is 6.41. Pediatrix Medical Group's value of 10.92% is 70.4% above this industry median. Overall, Pediatrix Medical Group has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's ROCE % compare to SGRY and ADUS?
Pediatrix Medical Group's ROCE % of 10.92% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Pediatrix Medical Group's value of 10.92% is 70.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current ROCE % of 10.92% is 70.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current ROCE % is 10.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (MEX:MD) has a current ROCE % of 10.92%. The stock's GF Value™ is MXN177.74, compared to a current price of MXN323.00 — trading 81.7% above its estimated fair value. The current ROCE % is 10.92% and 70.4% above the Healthcare Providers & Services industry median of 6.41. Pediatrix Medical Group's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Pediatrix Medical Group (MEX:MD), the current ROCE % is 10.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (MEX:MD) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of MXN323.00 is trading 81.7% above its estimated GF Value™ of MXN177.74.

Key valuation signals for MEX:MD:

  • ROCE %: 10.92%
  • GF Value™: MXN177.74 vs. price of MXN323.00 (81.7% above fair value)
  • GF Score™: 59/100 with 7 warning signs
  • Industry Position: 70.4% above the Healthcare Providers & Services median

No single metric tells the full story. See the MEX:MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pediatrix Medical Group Business Description

Other Exchanges MD:USAPDC:Germany
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
59GF Score

Get the complete analysis for MEX:MD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN323.00
Price
MXN177.74
GF Value